Skip to main content
. Author manuscript; available in PMC: 2021 May 19.
Published in final edited form as: Sci Transl Med. 2020 Jun 17;12(548):eaaz7715. doi: 10.1126/scitranslmed.aaz7715

Figure 1. Solicited adverse events within 7 days from vaccination.

Figure 1

Frequency of local and systemic adverse events recorded by volunteers on diary cards. The proportion of volunteers reporting symptoms at any time during 72 hours following (A) Low dose: ChAd3-hIiNSmut (5 x10^9 vp) (n=6); (B) Low dose: MVA-hIiNSmut (5 x10^7 pfu) (n=6), (C) Standard dose: ChAd3-hIiNSmut (2.5 x10^10 vp) (n=11); (D) Standard dose: MVA-hIiNSmut (2 x10^8 pfu) (n=10); (E) Standard dose: ChAd3-NSmut (2.5 x10^10 vp) and (F) Standard dose: MVA-NSmut (2 x10^8 pfu). Color code indicates maximum severity of the reaction reported: black– Grade 1 (mild); red– Grade 2 (moderate); blue-Grade 3 (severe).